2024 EULAR points to consider on the initiation of targeted therapies in patients with inflammatory arthritis and a history of cancer.
Sebbag E, Lauper K, Molina-Collada J, Aletaha D, Askling J, Gente K, Bertheussen H, Bitoun S, Bolek EC, Burmester GR, Canhão HM, Chatzidionysiou K, Curtis JR, Danlos FX, Guimarães V, Hetland ML, Iannone F, Kostine M, Kragstrup TW, Kvien TK, Regierer AC, Schulze-Koops H, Silva-Fernández L, Szekanecz Z, Buch MH, Finckh A, Gottenberg JE.
Sebbag E, et al. Among authors: canhao hm.
Ann Rheum Dis. 2024 Dec 20:ard-2024-225982. doi: 10.1136/ard-2024-225982. Online ahead of print.
Ann Rheum Dis. 2024.
PMID: 39739385